绿藻Caulerpa racemosa化合物作为SARS-CoV-2的抗病毒候选物:在体研究中
Asmi Cmar Tassakka1, Israini W Iskandar2, Andi Ba Juniyazaki3
1Faculty of Marine Science and Fisheries, Universitas Hasanuddin, Makassar, Indonesia.
Narra J
|March 8, 2024
概括
绿藻化合物显示出对SARS-CoV-2 (COVID-19) 的潜在抗病毒活性. 在分析中发现了Caulerpa racemosa的强效化合物,这表明它可以用作抗病毒候选物.
科学领域:
- 海洋生物学 海洋生物学
- 药理学 药理学是指药理学的学科.
- 计算化学计算化学
背景情况:
- 绿藻,特别是Caulerpa racemosa,具有生物活性化合物.
- 假设这些化合物对SARS-CoV-2具有抗病毒性质.
- SARS-CoV-2导致COVID-19大流行,需要新的治疗策略.
研究的目的:
- 为了研究来自Caulerpa racemosa的化合物的抗SARS-CoV-2潜力.
- 使用in silico分析来评估抗病毒活性.
- 为了识别具有与SARS-CoV-2目标高结合亲和度的特定化合物.
主要方法:
- 从Caulerpa racemosa中提取生物活性化合物,使用96%的乙醇.
- 通过气色谱-质谱学 (GC-MS) 识别化合物.
- 使用PyRx进行基分子对接,并使用PyMOL进行可视化,以评估与SARS-CoV-2 3C类蛋白酶的结合亲和关系.
主要成果:
- 在GC-MS分析中,Caulerpa racemosa提取物中发现了92种生物活性化合物.
- 六种化合物对SARS-CoV-2 3C类蛋白酶表现出强烈的结合亲和力.
- 一种特定的化合物,n-[1-(1-adamantan-1-yl-propyl) -2,5-dioxo-4-trifluoromethyl-imidazo lidin-4-yl]4-methoxy-benzamide,具有 -8.1 kcal/mol的结合评分,与remdesivir.com可比.
- 分子动力学模拟证实了已识别的抑制剂的稳定性.
结论:
- 在分析表明,Caulerpa racemosa提取物具有作为抗病毒剂对抗SARS-CoV-2的潜力.
- 已识别的化合物需要进一步研究以治疗开发.
- 这项研究强调了海洋天然产品在打击病毒感染方面的潜力.
相关概念视频
01:29Subviral Agents
861
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
861
01:30Inhibitors of Viral Protein Synthesis
35
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
35
01:15Antifungal Agents
89
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
89